Bioventus Director Michelle McMurry‑Heath Sells 12,000 Shares in Quiet March Move, No Signs of Wider Sell‑Off Wave
Bioventus insider sale: Michelle McMurry‑Heath sold 12,000 shares—small move but may hint at her risk appetite; the company’s growth outlook remains solid.
3 minutes to read
